Figure 3.
Sitagliptin treatment decreased valine levels in T2D patients. The relative level of valine in the T2D_Placebo and T2D_Sit groups. Data are presented as the means ± SD, t-test.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.